Danaher Corporation (DHR) Shares Bought by FineMark National Bank & Trust
FineMark National Bank & Trust raised its stake in shares of Danaher Corporation (NYSE:DHR) by 2.3% during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 75,457 shares of the conglomerate’s stock after buying an additional 1,666 shares during the period. FineMark National Bank & Trust’s holdings in Danaher Corporation were worth $6,368,000 at the end of the most recent reporting period.
Other large investors have also bought and sold shares of the company. Hudson Valley Investment Advisors Inc. ADV acquired a new stake in Danaher Corporation during the first quarter valued at about $567,000. Diversified Trust Co raised its stake in Danaher Corporation by 1.1% in the first quarter. Diversified Trust Co now owns 4,812 shares of the conglomerate’s stock valued at $412,000 after buying an additional 52 shares in the last quarter. Candriam Luxembourg S.C.A. raised its stake in Danaher Corporation by 24.9% in the first quarter. Candriam Luxembourg S.C.A. now owns 57,118 shares of the conglomerate’s stock valued at $4,886,000 after buying an additional 11,375 shares in the last quarter. Nationwide Fund Advisors raised its stake in Danaher Corporation by 16.8% in the first quarter. Nationwide Fund Advisors now owns 318,223 shares of the conglomerate’s stock valued at $27,218,000 after buying an additional 45,820 shares in the last quarter. Finally, Patriot Wealth Management Inc. raised its stake in Danaher Corporation by 3.2% in the first quarter. Patriot Wealth Management Inc. now owns 66,500 shares of the conglomerate’s stock valued at $5,688,000 after buying an additional 2,066 shares in the last quarter. 75.74% of the stock is owned by institutional investors.
Danaher Corporation (NYSE DHR) opened at 82.37 on Tuesday. The stock has a 50 day moving average price of $82.08 and a 200 day moving average price of $84.16. Danaher Corporation has a 12-month low of $75.71 and a 12-month high of $88.01. The stock has a market cap of $57.22 billion, a P/E ratio of 26.29 and a beta of 1.03.
Danaher Corporation (NYSE:DHR) last posted its earnings results on Thursday, July 20th. The conglomerate reported $0.99 earnings per share for the quarter, beating the consensus estimate of $0.97 by $0.02. The company had revenue of $4.51 billion for the quarter, compared to analyst estimates of $4.50 billion. Danaher Corporation had a net margin of 12.63% and a return on equity of 11.15%. Danaher Corporation’s revenue was up 6.3% on a year-over-year basis. During the same period in the previous year, the business posted $0.90 EPS. On average, analysts forecast that Danaher Corporation will post $3.95 earnings per share for the current fiscal year.
ILLEGAL ACTIVITY WARNING: “Danaher Corporation (DHR) Shares Bought by FineMark National Bank & Trust” was posted by The Cerbat Gem and is the sole property of of The Cerbat Gem. If you are accessing this report on another website, it was illegally stolen and reposted in violation of US & international copyright and trademark laws. The legal version of this report can be accessed at https://www.thecerbatgem.com/2017/08/29/danaher-corporation-dhr-shares-bought-by-finemark-national-bank-trust.html.
Several equities research analysts recently issued reports on DHR shares. Credit Suisse Group reissued a “buy” rating and set a $93.00 price objective on shares of Danaher Corporation in a research note on Wednesday, May 24th. Janney Montgomery Scott lowered Danaher Corporation from a “buy” rating to a “neutral” rating in a research note on Wednesday, June 7th. BidaskClub lowered Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Thursday, June 15th. Zacks Investment Research lowered Danaher Corporation from a “hold” rating to a “sell” rating in a research note on Monday, June 19th. Finally, Deutsche Bank AG reaffirmed a “buy” rating and set a $97.00 price target on shares of Danaher Corporation in a research note on Wednesday, June 21st. One equities research analyst has rated the stock with a sell rating, three have issued a hold rating, thirteen have given a buy rating and one has issued a strong buy rating to the stock. The stock presently has a consensus rating of “Buy” and a consensus price target of $91.76.
In other Danaher Corporation news, Director Linda P. Hefner sold 10,578 shares of the business’s stock in a transaction dated Friday, July 21st. The shares were sold at an average price of $83.03, for a total value of $878,291.34. Following the transaction, the director now directly owns 42,151 shares in the company, valued at approximately $3,499,797.53. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, insider Thomas Patrick Joyce, Jr. sold 9,772 shares of the business’s stock in a transaction dated Monday, July 31st. The shares were sold at an average price of $81.78, for a total transaction of $799,154.16. Following the completion of the transaction, the insider now owns 155,520 shares in the company, valued at $12,718,425.60. The disclosure for this sale can be found here. Insiders sold a total of 27,808 shares of company stock worth $2,296,236 over the last quarter. 12.20% of the stock is currently owned by company insiders.
About Danaher Corporation
Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.
Receive News & Stock Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related stocks with our FREE daily email newsletter.